Laboratory Animal Allergens

Animal allergens are considered a hazardous substance and long-term exposure can cause ill-health effects. Exposure to animal allergens occurs when people are exposed to urine, fur, hair, dander, saliva, droppings and serum sources.

Under the COSHH regulations, employers must prevent, or if this is not reasonably practicable, adequately control the exposure of employees to hazardous substances, including animal allergens.

Control measures must be in place for animal technicians, scientific staff, students, cleaning, maintenance staff, and lab visitors.

Typical symptoms include rhinitis, conjunctivitis and skin rashes. The condition may not only affect a person's health but their ability to continue working within an animal laboratory environment.

How our experts can help:

  • Allergen exposure monitoring to assess the concentration of allergens within the animal facility and to assess current levels of control.
  • Task-based exposure monitoring, e.g. cage cleaning, filter changes, animal handling.
  • Airflow measurements to calculate the number of air changes within rooms.
  • Local Exhaust Ventilation (LEV) thorough examination and testing.
  • Face fit testing of Respiratory Protective Equipment.
  • Assistance with risk assessment requirements.
  • Auditing assessments and safe systems of work.

For more advice, or to speak to an Occupational Hygienist complete the quick quote form below. 

EVENTS
20 October
2021
In partnership with the ICBA

Particles and Health 2021

  • 20 October 2021
  • Running from the 20.10.21 to 21.10.21

IOM is proud to be sponsoring the Particles and Health conference, a two day event designed for regulators and researchers to:

  • Address scientific studies regarding human health effects of PSLTs. The value of human studies over animal studies-when human-exposed populations can be studied adequately- will be emphasized.
  • Review and discuss definition of PSLT’s proposed at Edinburgh workshop and published in 2020 in the Journal Inhalation Toxicology with attention to both similarities and differences among these substances.
  • Address translational toxicology challenges, including the appropriateness of rats as models for human lung pathogenesis (particularly lung cancer) in light of lung overload phenomena and species differences.
  • Serve as a platform to present current scientific information about PSLTs important for regulatory action.
  • Publication of pertinent conference presentations in the peer reviewed scientific literature will allow the presentations to live beyond the conference and subsequently be reviewed part of regulatory deliberations.
  • Establish an interdisciplinary setting for industry, academia and regulatory professionals to interact on an important topic. Such interaction can facilitate enhanced understanding of the science and appropriate classification, labelling and setting exposure limits, among others.
  • Recommend areas for further research regarding the significance of the rat as a model for translation toxicology. 
  • Review the biokinetics of inhaled nanoparticles and the potential for non-pulmonary effects.

For more information and tickets please visit the Particles and Health website here.

Event info
We're here to provide you with more information and answer any questions you may have. Contact us